MHMark C. P. Haigney

Mark C. P. Haigney

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mark C. P. Haigney has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Shao‐Kui Wei

    Division of Cardiology, Department of Medicine, Uniformed Services University of the Health Sciences, A3060, USUHS, 4301 Jones Bridge Road, Bethesda, MD 20814, USA

    2 shared publications
  • Stephen U. Hanlon

    Division of Cardiology, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA

    2 shared publications
  • Ahmed Elkashef

    Divisions of Cardiology and Clinical Pharmacology and Medical Toxicology, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • Barry Stimmel

    Mount Sinai School of Medicine, New York, NY 10029, USA

    1 shared publication
  • C. Nora Chiang

    Divisions of Cardiology and Clinical Pharmacology and Medical Toxicology, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • Davendra Mehta

    Division of Cardiology, Mount Sinai Hospital and School of Medicine, New York, NY, USA

    1 shared publication

Latest Publications

  • QTc Interval Screening in Methadone Treatment

    by Mori J. Krantz, Judith Martin, Barry Stimmel, Davendra Mehta, Mark C.P. Haigney

    An independent panel developed cardiac safety recommendations for physicians prescribing methadone. Expert panel members reviewed and discussed the following sources regarding methadone: pertinent English-language literature identified from MEDLINE and EMBASE searches (1966 to June 2008), national substance abuse guidelines from the United States and other countries, information from regulatory authorities, and physician awareness of adverse cardiac effects. Clinicians should inform patients of arrhythmia risk when they prescribe methadone. Clinicians should ask patients about any history of structural heart disease, arrhythmia, and syncope. Obtain a pretreatment electrocardiogram for all patients to measure the QTc interval and a follow-up electrocardiogram within 30 days and annually. Additional electrocardiography is recommended if the methadone dosage exceeds 100 mg/d or if patients have unexplained syncope or seizures. If the QTc interval is greater than 450 ms but less than 500 ms, discuss the potential risks and benefits with patients and monitor them more frequently. If the QTc interval exceeds 500 ms, consider discontinuing or reducing the methadone dose; eliminating contributing factors, such as drugs that promote hypokalemia; or using an alternative therapy. Clinicians should be aware of interactions between methadone and other drugs that possess QT interval–prolonging properties or slow the elimination of methadone.


  • Gender Differences in Na/Ca Exchanger Current and β‐Adrenergic Responsiveness in Heart Failure in Pig Myocytes

    by Shao‐Kui Wei, John M. Mccurley, Stephen U. Hanlon, Mark C. P. Haigney

    Abstract:  Clinical trials suggest females experience less heart failure (HF) progression, mortality, and arrhythmia frequency. HF increases Na/Ca exchanger (NCX) expression and activity contributing to both depressed contractility and ventricular arrhythmias, but whether gender modifies this effect is unknown. Left ventricular myocytes were isolated from control and from tachycardic pacing‐induced failing swine hearts of both sexes. The Ni‐sensitive NCX current (INCX) was measured in voltage clamp after blocking other channels. In control myocytes there is no difference in basal INCX and β‐adrenergic responsiveness between male and female animals. HF greatly increased INCX and reduced β‐adrenergic responsiveness in males compared to females, an effect that was eliminated by PP1. Diuretic therapy (furosemide, 1 mg/kg/day) further enhanced INCX and reduced β‐adrenergic responsiveness in females and eliminated the gender difference. Gender‐specific differences in calcium handling may contribute to improved survival of females in HF.


  • Intravenous Cocaine and QT Variability

    by Mark C.P. Haigney, Shama ALAM, Scot Tebo, Gregary Marhefka, Ahmed Elkashef, Roberta Kahn, C. Nora Chiang, Frank Vocci, Louis Cantilena

    Background:Dynamic instability in cardiac repolarization may contribute to drug‐induced arrhythmogenesis. We hypothesized that intravenous cocaine would significantly destabilize repolarization as measured by QT variability.Methods and Results:Twenty‐nine cocaine‐experienced volunteers not seeking treatment for cocaine addiction received randomized, sequential intravenous infusions of placebo or cocaine (20 and 40 mg). Five‐minute epochs of digitized ECG were recorded 10 minutes before, during, and at intervals following the infusions. QT variability was measured using a semiautomated method and expressed as the log ratio of normalized QT variance to normalized heart rate variance (QTVI). Seventeen subjects received a repeat course of cocaine infusions 1 week later. Placebo infusion resulted in a small but significant increase in QTVI, while cocaine caused a highly significant, dose‐dependent increase in QTVI that peaked at 10 minutes and dissipated by 45 minutes following infusion (P < 0.0001). The increase in QTVI was reproducible at 1 week (P = 0.8).Conclusions:Cocaine injection results in a significant dose‐dependent increase in QT variability as indexed by QTVI. This destabilizing effect on repolarization may increase vulnerability to reentrant arrhythmias and may partially explain an increased risk of sudden cardiac death associated with cocaine use.


  • Beta‐Adrenergic Stimulation of Pig Myocytes with Decreased Cytosolic Free Magnesium Prolongs the Action Potential and Enhances Triggered Activity

    by Shao‐Kui Wei, Stephen U. Hanlon, Mark C.P. Haigney

    Beta‐Adrenergic Stimulation and Repolarization. Introduction: Heart failure results in chronic beta‐adrenergic stimulation, repolarization lability, and arrhythmias associated with early afterdepolarizations (EADs) and delayed afterdepolarizations (DADs). Having described a significant reduction in intracellular free magnesium ([Mg2+]i) in experimental heart failure, we asked whether a reduction in [Mg2+]i would delay repolarization or facilitate EADs and/or DADs. Methods and Results: Left ventricular myocytes were isolated from Yorkshire swine. Cytosolic free [Mg2+] was set at 0.12 mM (LoMg) or 1.2 mM (HiMg) through pipette dialysis. Action potentials (AP), Ca current (ICa), and sodium/calcium exchange current (INCX) were measured in the presence or absence of isoproterenol (2 μM) at 37°C. Under basal conditions (0.1‐Hz stimulation, 2 mM external [Ca2+]), reducing [Mg2+]i had no effect on AP duration and ICa but did significantly enhance INCX. In contrast, during superfusion with isoproterenol, reduced [Mg2+]i caused a significant increase in AP duration at both 50% and 90% repolarization (APD50 and APD90) compared with HiMg (P < 0.05). LoMg cells manifested a high incidence of triggered activities, including spontaneous AP, EADs, and DADs (83.3% in LoMg, n = 12 vs 38.3% in HiMg, n = 13; P < 0.05). ICa and INCX were significantly increased in LoMg cells compared with HiMg cells (P < 0.05). Conclusion: Decreased cytosolic free magnesium prolongs AP duration and increases the incidence of triggered activity during beta‐adrenergic stimulation. These effects may be due to increased ICa and INCX in the presence of reduced intracellular [Mg2+]. A magnesium‐dependent increase in triggered activity coupled with delayed repolarization during beta‐adrenergic stimulation could contribute to the arrhythmogenic substrate in heart failure.